Narrow-band imaging with magnification in Barrett’s esophagus: validation of a simplified grading system of mucosal morphology patterns against histology

Background and study aims: Validation of a simplified classification of mucosal morphology in prediction of histology in Barrett’s esophagus using narrow-band imaging with magnification (NBI-Z) and assessing its reproducibility by endoscopists experienced in the use of NBI (NBI-experts) and by endoscopists who were new to NBI (non-NBI-experts).

Patients and methods: In a prospective cohort study of 109 patients with Barrett’s esophagus at a single tertiary referral center, mucosal patterns visualized in Barrett’s esophagus on NBI-Z were classified into four easily distinguishable types: A, round pits with regular microvasculature; B, villous/ridge pits with regular microvasculature; C, absent pits with regular microvasculature; D, distorted pits with irregular microvasculature. The NBI-Z grading was compared with the final histopathological diagnosis, and positive (PPV) and negative predictive values (NPV) were calculated. The reproducibility of the grading was then assessed by NBI-expert and non-NBI-expert endoscopists, and interobserver and intraobserver agreement were calculated using κ statistics.

Results: Per-biopsy analysis: In 903 out of 1021 distinct areas (87.9 %) the NBI-Z grading corresponded to the histological diagnosis. Per-patient analysis: The PPV and NPV for type A pattern (columnar mucosa without intestinal metaplasia) were 100 % and 97 % respectively; for types B and C (intestinal metaplasia) they were 88 % and 91 % respectively, and for type D (high-grade dysplasia) 81 % and 99 % respectively. Inter- and intraobserver agreement: The mean κ values in assessing the various patterns were 0.71 and 0.87 in the non-expert group; 0.78 and 0.91 in the expert group.

Conclusions: This study has validated a simplified classification of the various morphologic patterns visualized in Barrett’s esophagus and confirmed its reproducibility when used by NBI-expert and non-NBI-expert endoscopists.

References

• 1 Devesa S S, Blot W J, Fraumeni Jr J F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States.  Cancer. 1998;  83 2049-2053
• 2 Jankowski J, Provenzale D, Moayyedi P. Oesophageal adenocarcinoma arising from Barrett’s metaplasia has regional variations in the West.  Gastroenterology. 2002;  122 588-590
• 3 Enzinger P C, Mayer R J. Esophageal cancer.  N Engl J Med. 2003;  349 2241-2252
• 4 Streitz Jr J M, Andrews C W, Ellis F H. Endoscopic surveillance of Barrett’s esophagus. Does it help?.  J Thoracic Cardiovasc Surg. 1993;  105 383-387
• 5 Guidelines for the diagnosis and management of Barrett’s columnar-lined oesophagus. A report of the Working Party of the British Society of Gastroenterology August 2005. Available at http://www.bsg.org.uk/pdf_word_docs/Barretts_Oes.pdf. Accessed 20 March 2008
• 6 Sampliner R E. Updated guidelines for the diagnosis, surveillance and therapy of Barrett’s oesophagus.  Am J Gastroenterol. 2002;  97 1888-1895
• 7 Cameron A, Carpenter H A. Barrett’s esophagus, high grade dysplasia, and early adenocarcinoma: a pathological study.  Am J Gastroenterol. 1997;  92 586-591
• 8 Van Dam J. Novel methods of enhanced endoscopic imaging.  Gut. 2003;  52 12-16
• 9 Hamamoto Y, Endo T, Nosho K. et al . Usefulness of narrow band imaging endoscopy for diagnosis of Barrett’s oesophagus.  J Gastroenterol. 2004;  39 14-20
• 10 Anagnostopoulos G K, Yao K, Kaye P. et al . Novel endoscopic observation in Barrett’s oesophagus using high resolution magnification endoscopy and narrow band imaging.  Aliment Pharmacol Ther. 2007;  26 501-507
• 11 Sharma P, Bansal A, Mathur S. et al . The utility of a novel narrow band imaging endoscopy system in patients with Barrett’s esophagus.  Gastrointest Endosc. 2006;  64 167-175
• 12 Kara M A, Ennahachi M, Fockens P. et al . Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett’s esophagus by using narrow band imaging.  Gastrointest Endosc. 2006;  64 155-166
• 13 Playford R J. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett’s oesophagus.  Gut. 2006;  55 442-443
• 14 Gono K, Obi T, Yamaguchi M. et al . Appearance of enhanced tissue features in narrow-band endoscopic imaging.  J Biomed Opt. 2004;  9 568-577
• 15 Sharma P, Dent J, Armstrong D. et al . The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria.  Gastroenterology. 2006;  131 1392-1399
• 16 Dixon M F. Gastrointestinal epithelial neoplasia: Vienna revisited.  Gut. 2002;  51 130-131
• 17 Skacel M, Petras R E, Granlich T L. et al . The diagnosis of low grade dysplasia in Barrett’s esophagus and its implication for disease progression.  Am J Gastroenterol. 2000;  95 3383-3387
• 18 Landis J R, Koch G G. The measurement of observer agreement for categorical data.  Biometrics. 1977;  33 159-174
• 19 Boyce H W. Barrett’s esophagus: endoscopic findings and what to biopsy.  J Clin Gastroenterol. 2003;  36 (Suppl) S6-S18
• 20 Canto M I, Setrakian S, Willis J. et al . Methylene blue-directed biopsies improve detection of metaplasia and dysplasia in Barrett’s oesophagus.  Gastrointest Endosc. 2000;  51 560-568
• 21 Sharma P, Weston A P, Topalovski M. et al . Magnification chromoendoscopy for detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus.  Gut. 2003;  52 24-27
• 22 Fortun P J, Anagnostopoulos G K, Kaye P. et al . Acetic acid-enhanced magnification endoscopy in the diagnosis of specialised intestinal metaplasia, dysplasia and early cancer in Barrett’s oesophagus.  Aliment Pharmacol Ther. 2006;  23 735-742
• 23 Olliver J R, Wild C P, Sahay P. et al . Chromoendoscopy with methylene blue and associated DNA damage in Barrett’s esophagus.  Lancet. 2003;  362 373-374